ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Provention Bio Initiates Trial Evaluating PRV-3279 in Lupus americanpharmaceuticalreview
August 09, 2019Provention Bio has dosed the first patients in its PREVAIL (PRV-3279 EVAluation In Lupus) study, a Phase 1b/2a clinical trial evaluating PRV-3279. PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface prote -
First Subject Dosed In Phase 1 Trial Evaluating INP105
americanpharmaceuticalreview
August 30, 2018Impel NeuroPharma announced the first subject has been dosed in a Phase 1, randomized, double-blind, placebo-and-active controlled crossover study of their intranasal olanzapine product, INP105, dosed via Impel's proprietary Precision Olfactory Delivery,
Pharma Sources Insight January 2025
